Almost 100,000 bottles of nasal spray were recalled for a "microbial failure" that led to multiple complaints from customers.

"Sinus passages can become inflamed from an infection or allergies leading to the trapping ... and easing sinus headache pain." Saline nasal sprays don't contain any medication, and they're ...

ARS Pharmaceuticals launched Neffy, the first FDA-approved needle-free epinephrine nasal spray for severe allergic reactions.

New York governor Kathy Hochul signed a bill to protect doctors prescribing abortion medications by allowing them to keep their names off pill ... for anonymity on prescription labels.

Nasal sprays ... If your allergies are not responding to over-the-counter medications, a healthcare professional can recommend stronger prescription treatments. For those experiencing frequent ...

The Food and Drug Administration (FDA) has expanded its approval of a ketamine-derived nasal spray, Spravato (esketamine), as a standalone therapy for adults with treatment-resistant depression.

The global landscape of neurological health is undergoing a transformative moment with a pioneering nasal spray that could potentially revolutionize Alzheimer‘s disease management. As ...

The results? A nasal spray of oxytocin significantly reduced acute feelings of loneliness in participants, especially during group therapy sessions, even months after treatment. In the study ...

The Union ministry of health has announced a significant amendment to the Drugs Rules, 1945, concerning Ayurvedic, Siddha, and Unani (ASU) nasal sprays. Through a notification, the government has ...

This can result from a cold, the flu, or allergies ... syrups, nasal sprays, and eye drops. Many antihistamines are available OTC, but some require a prescription. Although cold and flu ...

The US Food and Drug Administration (FDA) has approved a supplemental new drug application allowing esketamine nasal spray (Spravato; Johnson & Johnson) to be used as a standalone treatment in ...

A ketamine-based nasal spray is officially the first and only standalone therapy available for treatment-resistant depression in the US. The FDA first approved the Johnson & Johnson drug, called ...